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Background: Reversible cerebral vasoconstriction syndrome (RCVS) is an infrequent disease characterized by severe
headaches with or without focal neurological deficits or seizures and a reversible vasoconstriction of cerebral
arteries. The Orpha number for RCVS is ORPHA284388. However, RCVS triggered by blood transfusion is rare. Here
we provided the clinical, neuroimaging and outcome data of patients diagnosed with RCVS resulting from red
blood cells transfusion.
Methods: We retrospectively identified 7 patients presenting with RCVS after red blood cells transfusion from
January 2010 to May 2014. The information on clinical features, neuroimaging and outcome were collected and
analyzed.
Results: All 7 patients were Chinese women, with a mean age of 42 years (38–46). All the patients had severe
anemia (Hb level < 6 g/dl) caused by primary menorrhagia due to uterine myoma (n = 5) or end-stage renal disease
(n = 2) and severe anemia persisted for a average period of 4 months (2–6). Each patient received packed red blood
cells transfusion (average: 1580 ml) over a period of 2–5 days. Blood transfusion increased the hemoglobin level by
at least 4.5 g/dL from baseline. The neurological symptoms appeared a mean of 6.3 days (2–13) after the last blood
transfusion. Headache was the most frequent symptom and seizure, transient or persistent neurological disorders
were observed. Neuroimaging showed cortical subarachnoid hemorrhage (n = 2), focal intracerebral hemorrhage
(n = 2), localized brain edema (n = 3), cerebral infarction (n = 1), and posterior reversible encephalopathy syndrome
(n = 2). Cerebral vasoconstrictions were demonstrated by magnetic resonance angiography or cerebral angiography.
Arterial constriction reversed in all patients within 1 to 3 months of follow-up after disease onset and no relapse
was observed up to a mean of 17.1 ± 4.8 months of follow-up.
Conclusions: RCVS is a rare complication as a result of blood transfusion in patients with chronic severe anemia
and should be considered in patients who show severe headache or neurologic deficits after transfusion.
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Reversible cerebral vasoconstriction syndrome (RCVS) is
an infrequent disorder characterized by severe headaches
with or without focal neurological deficits or seizures
and a reversible segmental and multifocal vasoconstric-
tion of cerebral arteries [1]. The most common clinical
feature of RCVS is severe acute headache, often* Correspondence: weiyuetj@163.com
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unless otherwise stated.presenting as a thunderclap headache [2,3]. The major
complication of RCVS is ischemic or hemorrhagic
stroke, which may lead to transient or permanent symp-
toms. RCVS occurs predominantly in females with ages
close to 50 years [2]. The exact pathophysiology of
RCVS remains unknown and the prevailing hypothesis
favors an involvement of transient disturbance in the
control of cerebral vascular tone [4]. RCVS may occur
spontaneously or be provoked by various factors. The
most common factors are postpartum and exposure to
various vasoactive substances, including illicit drugs andhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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sion is a commonly used therapy for chronic severe
anemia, but it has not been considered as an etiology of
RCVS. So far only few cases have been reported [5,6].
In this report, we characterized the clinical features,
neuroimaging and outcome of patients diagnosed with
RCVS resulting from red blood cells transfusion.
Subjects and Methods
Patients who developed RCVS after receiving red blood
cells transfusion were retrospectively identified from
January 2010 to May 2014. The study was approved by
the hospital’s research ethics committee and written
consent was retrospectively obtained from patients and
their legal representatives.
The diagnosis of RCVS after blood transfusion was
based on the following criteria [2,7]:(1) acute and severe
headache (often thunderclap) with or without focal defi-
cits or seizures; (2) segmental vasoconstriction of
cerebral arteries confirmed by indirect (eg, magnetic
resonance or CT) or direct catheter angiography;
(3) complete or substantial normalization of arteries
within 12 weeks after clinical onset;(4) history of receiv-
ing red blood cells transfusion because of severe anemia
within 3 months. Seven patients were diagnosed in the
study based on imaging or neurological deficits. Among
them, 3 were from the emergency, 2 from neurology
outpatient clinic and the rest 2 from gynecology. Other
potential precipitating factors of RCVS, such as vaso-
active substance use, post-partum status and prior
immunosuppressant use, were excluded. In addition, all
the patients did not have medical or surgical conditions
associated with RCVS, including neurosurgical proce-
dures, head trauma, catecholamine-secreting tumors,
and carotid endarterectomy.
All patients underwent neuroimaging evaluations
within 7 days after admission. Neuroimaging examina-
tions included cerebral computed tomography (CT) scan
(n = 7); cerebral 1.5 or 3.0 Tesla MRI (n = 7) with diffu-
sion weighted-images (DWI), fluid-attenuated inversion
recovery (FLAIR) images, T1WI, and T2WI; two-
dimensional time-of-flight cerebral MR angiography
(MRA) and magnetic resonance venography (n = 5);
cervical and transcranial doppler ultrasonography (TCD)
(n = 6) and cerebral angiography (n = 2). The scans were
conducted and analyzed independently by a neuroradiol-
ogist and a neurologist.
Laboratory data were analyzed for all patients within
72 hours after admission, including routine blood tests,
liver and kidney function, C-reactive-protein level, erythro-
cyte sedimentation rate, antiphospholipid antibodies. Lum-
bar puncture was performed in 3 patients.
The data were collected through review of the medical
charts and interview with the patients and/or proxy,including: 1) sex, 2) age, 3) history of primary headache
disorders, hypertension, pregnancy, and delivery, 4) rea-
sons of anemia and total volume of red blood cell trans-
fusion, 5) medications and drugs taken before the onset
of the disorder, 6) detailed characteristics of present
headaches, blood-pressure, and neurological symptoms,
and 7) treatment and follow-up visits.
Results
All 7 patients were Chinese women, averaging 42 years
(38–46). The demographic characteristics of patients are
listed in Table 1. No patients had a history of hyper-
tension. The causes of severe anemia were primary
menorrhagia due to uterine myoma (n = 5) or end-
stage renal disease (n = 2). The duration of severe
anemia (Hb level < 6 g/dl) lasted for an average of
4 months (2–6). The hemoglobin before transfusions
was 2.6 g/dl (1.5-3.4). Each patient received packed
red blood cells (PRBCs) transfusion (average: 1580 ml
(750–2500)) over a period of 2–5 days. The patient’s
hemoglobin increased to an average of 10.2 g/dL (7.9-12.5)
after transfusion. Two patients received an operation of
total abdominal hysterectomy on the second day after
blood transfusion and one patient received 400 mL PRBCs
after surgery. Propofol, sufentanil and rocuronium were
used for anesthesia. Dezocine was administered and they
only described mild incisional pain.
Neurological symptoms and signs
The neurological symptoms occurred in patients 6.3 days
(2–13) after the last blood transfusion. Headache was
the most frequent symptom in all 7 patients, of which 2
with mild headache and the other 5 with multiple thun-
derclap headaches. All episodes of thunderclap head-
aches occurred when patients were at rest. Pain location
was bilateral in 3 patients. The maximal pain intensity
was graded as a mean of 9 on the verbal scale. Recurrent
thunderclap headaches occurred in 4 patients and the
duration of severe pain was about 60 min (45–70). Two
patients who had a history of migraine claimed that their
headaches were completely different from that of their
usual occurrence. Three patients had higher blood pres-
sure during their acute headache and none of the eleva-
tion of blood pressure was persistent.
Five patients displayed other neurological symptoms.
Focal deficits were seen in 5 patients and seizures oc-
curred in 3 patients. In addition, 2 patients had only
transient neurological symptoms, while 3 had a persist-
ent deficit. Moreover, 3 patients showed neurological
symptoms 1 to 4 days after headache onset, while other
2 had thunderclap headache concomitant to focal deficit.
Hemiparesis, visual symptoms, dysarthria were com-
mon symptoms. One patient had cognitive impairment
(mini-mental status examination [MMSE] score: 20).
Table 1 Demographics and clinical data in 7 patients with RCVS following red blood cells transfusion
Patients Sex/age
(years)
Cause of anemia Duration of anemia















2 1700/4 3.3/11.6 6 Mild headache, hemiplegia (L) cSAH constriction of MCA
2 F/38 Menometrorrhagia
(uterine myoma)
4 1800/4 2/12.5 2 Thunderclap headache cSAH, Diffuse distal constriction
of MCA and ACA
3 F/45 End stage renal
disease















bilateral ACA, MCA (L)
5 F/47 End stage renal
disease















4 1150/4 2.5/8.1 7 Mild headache, hemiplegia (L),
mild cognitive impairment,focal







ACA, anterior cerebral artery BT, blood transfusion; cSAH, cortical subarachnoid hemorrhage;F, female; FLAIR, fluid-attenuated inversion recovery; GTCS, generalized tonic-clonic seizure; Hgb, hemoglobin; MCA, middle
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ized tonic– clonic seizures (GTCS) and the rest had
focal motor seizure turning into GTCS.
Blood and cerebrospinal fluid analysis
The biochemical test showed elevated blood urea nitrogen
and serum creatinine in 2 patients with the end-stage
renal disease. CSF test were abnormal in 2 patients: 1 had
slightly elevated CSF WBC (10/mm3) and the other had
slightly elevated CSF protein level (49 mg/l). Both 2 pa-
tients showed elevated intracranial pressures (220 and
195 mmH2O respectively).
Neuroimaging
In all patients, CT scan was the first investigation. The
initial CT was scanned at a mean of 1.3 days after head-
ache onset, showing a cortical subarachnoid hemorrhage
(cSAH) in 2 patients and parenchymal hemorrhage in
another 2patients (Figure 1).
MRI scan images were apparently abnormal for all pa-
tients. MRI showed a small localized unilateral cortical
subarachnoid hemorrhage (n = 2), localized brain edema
(n = 3), focal intracerebral hemorrhage (n = 2) and cere-
bral infarction (n = 1). Two patients had MRI FLAIR
hypersignals consistent with PRES on the first MRI per-
formed at 5 days after headache onset (Figure 1).
MRA showed diffuse segmental arterial constriction in
5 patients (Figure 2). Among 7 patients who had at least
one TCD, 5 had increased arterial velocities with a
mean of 157 ± 20 cm/s on middle cerebral arteries
and 145 ± 14 cm/s on carotid siphons. Two patients
had a conventional 4-vessel angiography that showed
multifocal segmental arterial constriction (Figure 2).
No unruptured aneurysms, vertebral or carotid artery
dissection and venous sinus thrombosis were found
in the study.
Treatment
Nimodipine was used in 3 patients by initial intravenous
infusion (1–2 mg/h adapted to blood pressure levels)
followed by oral administration. The other 4 patients
received only oral administration of nimodipine (30 mg,Figure 1 Brain imaging in RCVS. (A) CT scan showing cSAH; (B) FLAIR sho
(C,D) MRI showing right hyperintense subcortical lesions consistent with va
resolution of the lesion after 12 weeks from the same patient as shown in3 times a day, adapted to blood-pressure levels). The
duration for the treatment was ranged from 4 to 8 weeks.
Antiepileptic treatments were used for all patients show-
ing seizure activity. It was noted that recurrent head-
ache, seizure and new neurological deficits occurred in
1 patient.
Follow-up and clinical outcome
Follow-up study demonstrated the reversibility of arterial
constriction in all patients within 1–3 months after dis-
ease onset, with a normal MRA (n = 5) or conventional
angiography (n = 1). All patients showed complete reso-
lution of the lesions. We observed that 1 patient showed
a decreased maximum mean flow velocity in the middle
cerebral arteries by the TCD test 30 days after onset and
that the vasoconstriction recovered 1 year after by DSA
examination.
The mean duration of follow-up was 17.1 ± 4.8 months.
All the patients had a resolution of severe headaches
and did not develop any other new neurological deficits
3–6 weeks after discharge. No recurrent RCVS or thun-
derclap headache occurred during the rest of follow-up.
Two patients received total abdominal hysterectomy.
Discussion
Several complications are associated with transfusion of
blood products, many of which can be grouped as im-
munological or infectious [8]. However, neurological
complications resulting from the blood transfusion has
been rarely reported. The present series of 7 consecutive
patients reported here is the largest group of RVCS
caused by PRBC transfusion. The diagnostic criteria in
the study allowed us to rule out other disorders respon-
sible for headache and cerebral arterial constrictions
such as primary or secondary cerebral angiitis or
vasospam complicating an aneurismal subarachnoid
hemorrhage. . None of the drugs used in anaesthesia of
2 patients has known sympathomimetic effects, which
could be explained as vasospasm [9].
All the cases in the study were exclusively female
patients at the middle ages with chronic severe anemia
(5 patients suffered menorrhagia and 2 patients had anwing bilateral hypersignals in the occipital lobes consistent with PRES;
sogenic edema and right brain hemorrhage;and cranial MRI showing
C.
Figure 2 Vascular imaging in RCVS. (A) MRA showing the multiple narrowings of bilateral middle cerebral artery (red arrow); (B) cerebral
angiography showing multiple narrowing and dilatations of middle cerebral artery (thin red arrow) and anterior cerebral artery (thick red arrow);
(C) follow up angiography showing resolution of cerebral vasoconstriction after treatment from the same patient.
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fusions (average: 1580 mL) over a period of 2–5 days.
Blood transfusion increased the hemoglobin level by at
least 4.5 g/dL from baseline (average increase: 7.6 g/dL).
Braun et al. reported previously that patient may present
with symptomatic RCVS 3 months after transfusion [7].
However, in our cases, the neurological symptoms
appeared an average of 6.3 days after the last blood
transfusion. The discrepancy between the observations
between our study and others [7] is still not clear.
Our results further confirmed that thunderclap head-
ache is the clinical hallmark of RCVS [2]. These hyper-
acute and excruciating headaches were immediately
recognized by the difference from their previous head-
ache in the patients who had a history of migraine. Some
patients with RCVS may present mild headache [2]. For
instance, two patients showed mild headache in our
study. Different degrees of vasospasm in different vascu-
lar beds in the central nervous system may be respon-
sible for the varying severity of headaches in different
patients.
In addition to headache, focal neurological deficits of
varying severity and seizures were frequent symptoms.
cSAH occurred in 2 patients, while focal intracerebral
hemorrhages were found in another 2 patients. They
occurred early in the course of RCVS and were revealed
mostly by a persisting focal deficit concomitant with
thunderclap headache. Three patients were found with
local brain edemas on MRI images and 2 patients had
MRI FLAIR hypersignals, which were consistent with
PRES. In our study, only 1 patient showed infarction at
the surrounding regions in PRES.
There have been no reports of RCVS that occurs as a
result of transfused blood products under conditions of
acute blood loss. It has been hypothesized that chronic
anemia may be accompanied by cerebral vasodilatation
to compensate for ischemic hypoxia [10]. A rapid in-
crease in the hemoglobin level and viscosity during
blood transfusion might result in a loss of vasodilation
and increase in vascular resistances, which causeultimately overwhelming cerebral vessel constriction.
This resembled to a cerebral hyperperfusion syndrome
after carotid endarterectomy or stenting in carotid sten-
osis [11,12]. Immunologic and biochemical factors, in-
cluding endothelin-1, catecholamines, and nitric oxide,
might play a role in the pathophysiology of vasoconstric-
tion in RCVS [13]. The latencies from autoregulatory
breakthrough to symptom onset and vasoconstriction of
major cerebral arteries may depend on the patients’ con-
ditions, underlying diseases, amount and duration of
blood transfusion [8,9,14]. Another factor for the delayed
onset of vasoconstriction might be related to the tem-
poral course of centripetal progression of the vasocon-
strictions. The disturbance in the control of cerebral
arterial tone might first involve small distal arteries,
which were beyond the imaging studies [2]. Injury re-
lated to reperfusion may lead to the release of free radi-
cals and trigger dysfunction of the endothelium, which
may further aggravate cerebral vasoconstriction and
damage to the vascular endothelial system, resulting in a
vicious cycle. There have been reported that analgesics
or emotion might trigger RCVS. In the study, dezocine
was administered to alleviated pain for 2 total abdominal
hysterectomy patients.
Therefore, we couldn’t exclude the possibility that
analgesic or emotional distress potentially cause sympa-
thetic activation and contribute to RCVS [15].
The occurrence of PRES has already been reported in
RVCS [16]. PRES and RCVS share many clinicoradio-
graphic features, including similar predisposing factors,
clinical presentations, and clinical courses, suggesting
that they may have similar pathophysiological mecha-
nisms. It was possible that endothelial dysfunction after
blood transfusion affected the regulation of cerebral ar-
terial tone and triggered vasoconstriction with subse-
quent hypoperfusion, breakdown of the blood–brain
barrier, and vasogenic oedema.
Although the use of nimodipine is controversial in the
treatment of RCVS, it seemed to be effective in our
study. The favorable response to nimodipine might be
Liang et al. Orphanet Journal of Rare Diseases  (2015) 10:47 Page 6 of 6partly due to its role in preventing vasospasm or its
effect on the endothelium [17]. Consistent with the pre-
vious literatures [1], clinical outcome of our patients was
globally well.
According to previous reports, females were predom-
inantly susceptible to RCVS. Also, most cases of PRES
after blood transfusion that have been described in the
literature were Asian patients [5]. We couldn’t exclude
the possibility that there was an ethnic difference in the
occurrence of blood transfusion associated RCVS.
Conclusion
In conclusion, our cases presented in this report sug-
gested that RCVS was one of the complications resulting
from the blood transfusion in patients with chronic se-
vere anemia, in particular, in women with menorrhagia.
RCVS should be considered in patients if they developed
a severe headache or neurologic deficit after transfusion.
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